{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:26:46Z","timestamp":1794673606797,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":189,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002239","name":"Muskingum County Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000082","name":"Division of Graduate Education","doi-asserted-by":"publisher","award":["DGE-1747503"],"award-info":[{"award-number":["DGE-1747503"]}],"id":[{"id":"10.13039\/100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-1350178"],"award-info":[{"award-number":["CBET-1350178"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007925","name":"Waisman Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["R01EY024995"],"award-info":[{"award-number":["R01EY024995"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["T32HG002760"],"award-info":[{"award-number":["T32HG002760"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["F30EY027699"],"award-info":[{"award-number":["F30EY027699"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30EY027699"],"award-info":[{"award-number":["F30EY027699"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HG002760"],"award-info":[{"award-number":["T32HG002760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY024995"],"award-info":[{"award-number":["R01EY024995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM119644"],"award-info":[{"award-number":["R35GM119644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY024588"],"award-info":[{"award-number":["R01EY024588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ajhg.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T10:42:04Z","timestamp":1595500924000},"page":"278-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy"],"prefix":"10.1016","volume":"107","author":[{"given":"Divya","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Steyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan K.","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa","family":"Valiauga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Bacig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Steltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Cory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswesh","family":"Periyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Fotuhi","family":"Siahpirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin M.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budd A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash R.","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2020.06.011_bib1","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2020.06.011_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.09.012","article-title":"Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results","volume":"197","author":"Lam","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ajhg.2020.06.011_bib3","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I\/IIa Trial by Intravitreal Delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ajhg.2020.06.011_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajhg.2020.06.011_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature.2017.22819","article-title":"FDA advisers back gene therapy for rare form of blindness","volume":"550","author":"Ledford","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2020.06.011_bib6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In\u00a0Vivo CRISPR\/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ajhg.2020.06.011_bib7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajhg.2020.06.011_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/crispr.2017.0009","article-title":"Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa","volume":"1","author":"Li","year":"2018","journal-title":"CRISPR J"},{"key":"10.1016\/j.ajhg.2020.06.011_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2020.06.011_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/gt.2015.82","article-title":"CRISPR\/Cas9 DNA cleavage at SNP-derived PAM enables both in\u00a0vitro and in\u00a0vivo KRT12 mutation-specific targeting","volume":"23","author":"Courtney","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ajhg.2020.06.011_bib11","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ymthe.2018.06.002","article-title":"Global Transcriptional Response to CRISPR\/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells","volume":"26","author":"Cromer","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ajhg.2020.06.011_bib12","doi-asserted-by":"crossref","first-page":"E11257","DOI":"10.1073\/pnas.1714640114","article-title":"Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci","volume":"114","author":"Lessard","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.06.011_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2020.06.011_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.preteyeres.2017.01.005","article-title":"Bestrophinopathy: An RPE-photoreceptor interface disease","volume":"58","author":"Guziewicz","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ajhg.2020.06.011_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.preteyeres.2017.01.006","article-title":"Bestrophin 1 and retinal disease","volume":"58","author":"Johnson","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ajhg.2020.06.011_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature13913","article-title":"Structure and insights into the function of a Ca(2+)-activated Cl(-) channel","volume":"516","author":"Kane Dickson","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2020.06.011_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/hmg\/dds469","article-title":"iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration","volume":"22","author":"Singh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2020.06.011_bib18","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/mt.2015.141","article-title":"Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular Degeneration","volume":"23","author":"Singh","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ajhg.2020.06.011_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.stemcr.2017.12.004","article-title":"Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection","volume":"10","author":"Steyer","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.ajhg.2020.06.011_bib20","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1182\/blood-2010-07-298331","article-title":"Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells","volume":"117","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajhg.2020.06.011_bib21","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1167\/iovs.13-11943","article-title":"Functional analysis of serially expanded human iPS cell-derived RPE cultures","volume":"54","author":"Singh","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ajhg.2020.06.011_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1085\/jgp.115.1.59","article-title":"Bimodal control of a Ca(2+)-activated Cl(-) channel by different Ca(2+) signals","volume":"115","author":"Kuruma","year":"2000","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.ajhg.2020.06.011_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.3583","article-title":"Analyzing CRISPR genome-editing experiments with CRISPResso","volume":"34","author":"Pinello","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2020.06.011_bib24","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/hmg\/ddq129","article-title":"Transcriptome analysis and molecular signature of human retinal pigment epithelium","volume":"19","author":"Strunnikova","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2020.06.011_bib25","first-page":"556","article-title":"Algorithms for Non-negative Matrix Factorization","volume":"13","author":"Lee","year":"2000","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.ajhg.2020.06.011_bib26","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/hmg\/ddy070","article-title":"BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes","volume":"27","author":"Milenkovic","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2020.06.011_bib27","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1038\/s41598-018-21651-z","article-title":"Mutant Best1 Expression and Impaired Phagocytosis in an iPSC Model of Autosomal Recessive Bestrophinopathy","volume":"8","author":"Marmorstein","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ajhg.2020.06.011_bib28","doi-asserted-by":"crossref","first-page":"E2839","DOI":"10.1073\/pnas.1720662115","article-title":"BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by\u00a0light exposure","volume":"115","author":"Guziewicz","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.06.011_bib29","doi-asserted-by":"crossref","first-page":"e29914","DOI":"10.7554\/eLife.29914","article-title":"Patient-specific mutations impair BESTROPHIN1's essential role in mediating Ca2+-dependent Cl- currents in human RPE","volume":"6","author":"Li","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.ajhg.2020.06.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22270","article-title":"Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review","volume":"22","author":"Waugh","year":"2018","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ajhg.2020.06.011_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajhg.2018.12.019","article-title":"Gene Augmentation and Readthrough Rescue Channelopathy in an iPSC-RPE Model of Congenital Blindness","volume":"104","author":"Shahi","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2020.06.011_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2020.06.011_bib33","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2016.05.053","article-title":"Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine","volume":"165","author":"Popp","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2020.06.011_bib34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","article-title":"The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy","volume":"51","author":"Lindeboom","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2020.06.011_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3179","article-title":"Safe harbours for the integration of new DNA in the human genome","volume":"12","author":"Sadelain","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ajhg.2020.06.011_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","article-title":"Predictable and precise template-free CRISPR editing of pathogenic variants","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2020.06.011_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2009.04.002","article-title":"The spectrum of ocular phenotypes caused by mutations in the BEST1 gene","volume":"28","author":"Boon","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ajhg.2020.06.011_bib38","doi-asserted-by":"crossref","first-page":"19026","DOI":"10.1038\/s41598-019-54892-7","article-title":"Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations","volume":"9","author":"Ji","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ajhg.2020.06.011_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.exer.2014.02.006","article-title":"Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1","volume":"121","author":"Johnson","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ajhg.2020.06.011_bib40","doi-asserted-by":"crossref","first-page":"e61396","DOI":"10.1371\/journal.pone.0061396","article-title":"AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models","volume":"8","author":"Vasireddy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.06.011_bib41","doi-asserted-by":"crossref","first-page":"E7399","DOI":"10.1073\/pnas.1614688113","article-title":"Distinct regions that control ion selectivity and calcium-dependent activation in the bestrophin ion channel","volume":"113","author":"Vaisey","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.06.011_bib42","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.06.011_bib43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2020.06.011_bib44","doi-asserted-by":"crossref","first-page":"e2005840","DOI":"10.1371\/journal.pbio.2005840","article-title":"In\u00a0vitro-transcribed guide RNAs trigger an innate immune response via the RIG-I pathway","volume":"16","author":"Wienert","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ajhg.2020.06.011_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1535-7597.2004.42010.x","article-title":"Inherited Channelopathies Associated with Epilepsy","volume":"4","author":"George","year":"2004","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.ajhg.2020.06.011_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gim.2014.9","article-title":"Nicotinic acetylcholine receptors in human genetic disease","volume":"16","author":"Schaaf","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ajhg.2020.06.011_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fncel.2016.00081","article-title":"Potassium Channels and Human Epileptic Phenotypes: An Updated Overview","volume":"10","author":"Villa","year":"2016","journal-title":"Front. Cell. Neurosci."}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929720301993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929720301993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:08:11Z","timestamp":1777378091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929720301993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0002929720301993"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2020.06.011","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society of Human Genetics.","name":"copyright","label":"Copyright"}]}}